| Income Statement |
| Total Revenue | 43.75M |
|
| Revenues (USD) | 43.75M |
| Cost of Revenue | 21.80M |
| Gross Profit | 21.95M |
| Operating Expenses | 32.50M |
| Research and Development Expense | 5.78M |
| Selling, General and Administrative Expense | 26.72M |
| Operating Income | -10.55M |
| Interest Expense | 965.00K |
| Net Income | -9.30M |
| Net Income Common Stock | -9.30M |
| Net Income Common Stock (USD) | -9.30M |
| Consolidated Income | -9.30M |
| Earnings per Basic Share | -0.05 |
| Earnings per Basic Share (USD) | -0.05 |
| Earnings per Diluted Share | -0.05 |
| Earning Before Interest & Taxes (EBIT) | -8.33M |
| Earning Before Interest & Taxes (USD) | -8.33M |
| Weighted Average Shares | 180.10M |
| Weighted Average Shares Diluted | 180.10M |
| Balance Sheet |
| Cash and Equivalents | 53.43M |
| Cash and Equivalents (USD) | 53.43M |
| Investments | 9.94M |
| Investments Current | 9.94M |
| Trade and Non-Trade Receivables | 39.58M |
| Current Assets | 149.41M |
| Property, Plant & Equipment Net | 140.39M |
| Total Assets | 302.02M |
| Debt Current | 3.12M |
| Total Debt | 41.57M |
| Current Liabilities | 126.85M |
| Debt Non-Current | 38.45M |
| Total Liabilities | 183.17M |
| Accumulated Retained Earnings (Deficit) | -402.11M |
| Accumulated Other Comprehensive Income | -113.00K |
| Shareholders Equity | 118.86M |
| Shareholders Equity (USD) | 118.86M |
| Assets Non-Current | 152.62M |
| Total Debt (USD) | 41.57M |
| Deferred Revenue | 92.25M |
| Inventory | 8.66M |
| Liabilities Non-Current | 56.32M |
| Trade and Non-Trade Payables | 12.25M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.58M |
| Net Cash Flow from Financing | 245.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.65M |
| Capital Expenditure | -9.81M |
| Issuance (Purchase) of Equity Shares | 245.00K |
| Net Cash Flow from Investing | -14.80M |
| Net Cash Flow - Investment Acquisitions and Disposals | -4.99M |
| Net Cash Flow from Operations | 11.90M |
| Share Based Compensation | 6.85M |